Navigation Links
Cerulean Pharma to Present Data on CRLX101's HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
Date:4/4/2013

CAMBRIDGE, Mass., April 4, 2013 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that researchers will present both pre-clinical and clinical data on Cerulean's Phase 2 candidate, CRLX101, in sessions at the American Association for Cancer Research (AACR) Annual Meeting. Among the findings, Cerulean will share clinical data from a study evaluating synergy between CRLX101 and Avastin® (bevacizumab).

(Logo:  http://photos.prnewswire.com/prnh/20130107/NE37515LOGO )

In multiple animal models, CRLX101 inhibits hypoxia-inducible factor 1a (HIF-1a), which is involved in cancer survival mechanisms, and which is up-regulated in the hypoxic conditions created by anti-angiogenic drugs. Animal models suggest that CRLX101 is synergistic with multiple anti-angiogenic drugs, and this hypothesis is being tested in a clinical trial combining CRLX101 with Avastin, the leading anti-angiogenic medicine.

Dr. Stephen M. Keefe , the Ann B. Young Assistant Professor in Cancer Research at the Perelman School of Medicine at the University of Pennsylvania, will present a poster entitled A Phase Ib-2a Study Evaluating the Nanopharmaceutical CRLX101 in Combination with Bevacizumab (April 9, 8:00 am – 12:00 pm) on a clinical trial studying synergy between CRLX101 and Avastin when combined to treat patients with advanced renal cell carcinoma. Dr. Keefe, who practices at the Abramson Cancer Center of the University of Pennsylvania, will present data showing that the CRLX101-Avastin combination has been well tolerated in six patients treated to date with no dose limiting toxicities observed. Additional patients are being enrolled in the study to confirm combinability and to assess efficacy.

"The pre-clinical data for CRL
'/>"/>

SOURCE Cerulean Pharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cerulean Pharmas Lead Candidate Selected as a "Top 10 Oncology Project to Watch"
2. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
3. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
4. Valeant Pharmaceuticals Provides Update to Recent Event
5. X-BODY Announces Multi-Million Dollar Development Alliance With Jiangsu Hengrui Medicine Co., Ltd., A Leading Pharmaceutical Company In China, To Develop Novel Therapeutic Antibodies For AMD
6. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
7. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
8. DFH Pharma, USA Partners with Hetero Group, INDIA to Develop 2nd Generation HIV Maturation Inhibitor Drugs
9. Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
10. Kentucky Health Cooperative To Partner With ProCare Rx For Pharmacy Benefit Management
11. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)...  (MUSE Booth # 1510)What:Automating continuous vital sign ... invaluable in any hospital setting, but particularly for ... and mainstream in healthcare, the integration of data ... gaining traction in MEDITECH facilities.During MUSE 2015 (Medical ... Manager & Clinical Analyst at McLaren Huron Hospital, ...
(Date:5/21/2015)... WASHINGTON , May 21, 2015 ... Century Cures legislation by the House Energy ... (SCPC) thanked the Committee for recognizing the unique ... providers, and for including bill language exempting Part ... settings from a proposed medication management "lock-in" provision. ...
(Date:5/21/2015)... and SEATTLE , May 21, 2015 ... development of robotics, sensors and medical devices, announced today ... company,s Chief Financial Officer and head of Corporate Development ... corporate development, business development and finance roles, including positions ... Pendrell Corporation.  Mr. Woo will be located in Sarcos, ...
Breaking Medicine Technology:Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3SCPC Applauds Unanimous House Panel Passage of 21st Century Cures Bill Recognizing Unique Challenges Facing Long Term Care (LTC) Pharmacy Patients, Providers 2Sarcos Corp. Announces Preston Woo as CFO and Head of Corporate Development 2
(Date:5/21/2015)... Ticket Down is a reliable source for authentic ... Guatemala on Friday, July 3rd at LP Field in Nashville, ... fan of international soccer. The number of chances to watch some ... is growing at a large clip. Over the past several years, ... USA to play in front of the American people. The match ...
(Date:5/21/2015)... 21, 2015 Bird B Gone, the leader ... recently added new sizes of the Bird Spike 2001 to ... stainless steel bird spike is specifically designed to reduce ... on roof lines, parapet walls, I-beams, window ledges and more. ... 100 foot boxes, allowing customers to buy the right amount ...
(Date:5/21/2015)... Colorado (PRWEB) May 21, 2015 ... American Hemp Exchange, the first fully electronic marketplace ... provide a comprehensive electronic marketplace in which wholesale ... or exchange their hemp-related inventories on a fully ... to meet this demand through a unique blend ...
(Date:5/21/2015)... Shimadzu Scientific Instruments today announces ... features new time-saving tools to maximize laboratory productivity. ... headspace, and solid-phase microextraction (SPME), the AOC-6000 features ... users to seamlessly change injection techniques before starting ... new autosampler allows for sample preparation to be ...
(Date:5/21/2015)... LOS ANGELES, CA (May 21, 2015) – BeMyDD (Be ... announced the launch of a new responsibility campaign to curb ... will receive $20 off their first ride by using promo ... prize of a “DD For a Year” (a $2000 value). ... start of the summer season, also marks the beginning of ...
Breaking Medicine News(10 mins):Health News:USA vs. Guatemala Tickets: Ticket Down Slashes United States Men's Soccer Team (USMNT) vs. Guatemala Tickets at LP Field in Nashville on 7/3/15 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 2Health News:Bird B Gone, Inc. Offers New Box Sizes of Stainless Steel Bird Spikes 3Health News:Amercanex is Revolutionizing Order and Efficiency in the Hemp Industry 2Health News:Shimadzu’s New AOC-6000 Autosampler Makes Automated Sample Introduction Simple and Efficient 2Health News:BeMyDD Announces Memorial Day Weekend Campaign to Decrease Drunk Driving Nationwide 2
... leverage Risk MonitorPro, (R) and Feedback ... patient feedback and adverse events,CAMBRIDGE, MA, Jan. 13 ... quality and safety software, announced today that Woman,s Hospital ... and quality of care initiatives. , Named by Modern ...
... Straight Wire Seminars(TM) Celebrates 3 Decades of Orthodontic ... Straight Wire Seminars , Inc., a leading provider ... 30th anniversary starting this month, January 2009. ... milestone by offering a wide array of courses ...
... to enter Animal Health Rapid Diagnostics Market with a ... 13 Abaxis, Inc. (Nasdaq: ABAX ), ... for both the medical and veterinary markets, announced today ... for the manufacturing of a Canine Heartworm Lateral Flow ...
... Merck Serono and Apitope to Collaborate on Development ... the Treatment of Multiple Sclerosis (MS)GENEVA, Jan. 13 ... Darmstadt, Germany, announced today the signature of a ... (Bristol) Ltd., a wholly owned subsidiary of Apitope ...
... The National Eczema Association (NEA) awarded its Seal ... Theraplex Clear Lotion .The NEA Seal of Acceptance is ... program, which is intended to improve the quality of ... skin. "These products met our criteria for having no ...
... and Web 2.0 as Top Security Concerns and Steps Organizations Need to ... ... Ariz. (PRWEB) January 13, 2009 -- What will be the biggest threats ... 24 months? Cybercrime, data breaches , Web 2.0 and outsourcing were ...
Cached Medicine News:Health News:Woman's Hospital Selects rL Solutions for Improved Adverse Event and Patient Safety Reporting 2Health News:Don't Trust Any Continuing Education Provider Under 30 2Health News:Don't Trust Any Continuing Education Provider Under 30 3Health News:ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd. 2Health News:ABAXIS Announces Contract Manufacturing Agreement with SA Scientific, Ltd. 3Health News:Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis 2Health News:Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis 3Health News:Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis 4Health News:National Eczema Association Anoints Theraplex Products with Seal of Acceptance 2Health News:Lumension Security Webinar Focuses on Security Mega Trends and Emerging Threats in 2009 2Health News:Lumension Security Webinar Focuses on Security Mega Trends and Emerging Threats in 2009 3
Bipolar forceps...
... in vitro Nucleic Acid Hybridization ... Microplate Chemiluminescence for the Qualitative ... Types 6,11,16,18,31,33,35,39,42,43,44,45,51,52,56,58,59 and 68 and ... High-Risk Groups in Cervical Specimens: ...
... superb radiation protection-0.62mm (+/- .05)Pb lead glass ... to their level of protection, they are ... smoothly on your bridge while hugging your ... wear corrective lenses, you can order Leaded ...
... first time in the world, there is a ... to diagnose VVC in female patients. CanDia5® is ... detect the Candida antigens almost instantaneously (within 5 ... blood. There is no similar POC product for ...
Medicine Products: